Clinical trial
Multi-institutional Analysis of Survival and Recurrence Patterns of Different Pathological Regression Types After Neoadjuvant Chemoradiotherapy or Radiotherapy for Esophageal Squamous Cell Carcinoma
NCT06241079 is registered in ClinicalTrials.gov with Tianjin Medical University Cancer Institute and Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multi-institutional Analysis of Survival and Recurrence Patterns of Different Pathological Regression Types After Neoadjuvant Chemoradiotherapy or Radiotherapy for Esophageal Squamous Cell Carcinoma
- Lead sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2003
- Completion date
- February 1, 2023
- Enrollment
- 582 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.